Trial Profile
Maintenance Nab-Paclitaxel After Cisplatin-Based Neoadjuvant Chemotherapy in Patients With High Risk Bladder Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 14 Apr 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 30 Mar 2016 New trial record